Cathepsin A/protective protein: An unusual lysosomal multifunctional protein

Cellular and Molecular Life Sciences

Volumn 56, Issue 11-12, 1999, Pages 894-907

  Hiraiwa, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hydrolase fold; galactosidase; Carboxypeptidase; Cathepsin A; Deamidase; Enzyme complex; Esterase; Galactosialidosis; Lysosomal protective protein; Neuraminidase; Peptide hormones

Indexed keywords

AMIDASE; BETA GALACTOSIDASE; CARBOXYPEPTIDASE C; ESTERASE; LYSOSOME ENZYME; PEPTIDE HORMONE; SERINE PROTEINASE; SIALIDASE; TACHYKININ; THROMBOCYTE ENZYME;

AMINO ACID SEQUENCE; COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME SPECIFICITY; GALACTOSIALIDOSIS; GENE MUTATION; HUMAN; HYDROLYSIS; KNOCKOUT MOUSE; PROTEIN DEGRADATION; REVIEW; TISSUE DISTRIBUTION;

AGE OF ONSET; AMINO ACID SEQUENCE; ANIMALS; BETA-GALACTOSIDASE; CARBOXYPEPTIDASE C; CARBOXYPEPTIDASES; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; MUTATION; NEURAMINIDASE; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; SUBSTRATE SPECIFICITY;

SACCHAROMYCES CEREVISIAE;

EID: 0033385805     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050482     Document Type: Review

References (116)

1. 1 Bohley P. and Seglen P. O. (1992) Proteases and proteolysis in the lysosome. Experientia 48: 151-157
2. 2 Chatterjee R. and Kalnitsky G. (1986) The specificity of rabbit lung cathepsin I on biopeptides. Biomed. Biochim. Acta 45: 1447-1455
3. 3 Velasco G., Ferrando A. A., Puente X. A., Sanchez L. M. and Lopez-Otin C. (1994) Human cathepsin O. J. Biol. Chem. 269: 27136-27142
4. 4 Adachi W., Kawamoto S., Ohno I., Nishida K., Kinoshita S., Matsubara K. et al. (1998) Isolation and characterization of human cathepsin V: a major proteinase in corneal epithelium. Invest. Ophthalmol. Vis. Sci. 39: 1789-1796
5. 5 Linnevers C., Smeekens S. P. and Bromen D. (1997) Human cathepsin W, a putative cystein protease predominantly expressed in CD8 + T-lymphocytes. FEBS Lett. 405: 253-259
6. 6 Nagler D. K. and Menard R. (1998) Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions. FEBS Lett. 434: 135-139
7. 7 Santamaria I., Velasco G., Pendas A. M., Fueyo A. and Lopez-Otin C. (1998) Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and a unique chromosomal location. J. Biol. Chem. 273: 16816-16823
8. 8 Langner J., Kirschke H., Bohley P., Wiederanders B. and Korant B. D. (1982) The ribosomal serine proteinase, cathepsin R occurrence in rat liver ribosomes in a cryptic form. Eur. J. Biochem. 125: 21-26
9. 9 Barrett A. J. (1981) Cathepsin G. Methods Enzymol. 80: 561-565
10. 10 Pontremoli S., Melloni E., Salamino F., Sparatore B., Michetti M. and Horeeker B. L. (1982) Cathepsin M: a lysosomal proteinase with aldolase-inactivating activity. Arch. Biochem. Biophys. 214: 376-385
11. 11 Nishimura Y., Kawabata T. and Kalo K. (1988) Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch. Biochem. Biophys. 261: 64-71
12. 12 McDonald J. K. and Emerick J. M. C. (1995) Purification and characterization of procathepsin L, a self-processing zymogen of guinea pig spermatozoa that acts on a cathepsin D assay substrate. Arch. Biochem. Biophys. 323: 409-422
13. 13 Hiraiwa M., Martin B. M., Kishimoto Y., Conner G. E., Tsuji S. and O'Brien J. S. (1997) Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. Arch. Biochem. Biophys. 341: 17-24
14. 14 McQueney M. S., Amegadzie B. Y., D'Alessio K., Hanning C. R., McLaughlin M. M., McNulty D. et al. (1997) Autocatalytic activation of human cathepsin K. J. Biol. Chem. 272: 13955-13960
15. 15 Gelb B. D., Shi G. P., Chapman H. A. and Desnick R. J. (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273: 1236 1238
16. 16 Riese R. J., Mitchell R. N., Villadangos J. A., Shi G. P., Palmer J. T., Karp E. R. et al. (1998) Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101: 2351-2363
17. 17 Mizote A., Okamoto S. and Iwao Y. (1999) Activation of Xenopus eggs by proteases: possible involvement of a sperm protease in fertilization. Dev. Biol. 208: 79-92
18. 18 Barrett A. J. and Kirschke H. (1981) Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol. 80: 535-561
19. 19 Lynn K. R. and Labow R. S. (1984) A comparison of four sulfhydryl cathepsins (B, C, H, and L) from porcine spleen. Can. J. Biochem. Cell Biol. 62: 1301-1308
20. 20 Fruton J. S. and Bergmann M. (1939) On the proteolytic enzymes of animal tissues. J. Biol. Chem. 130: 17-27
21. 21 McDonald J. K. and Schwabe C. (1977) Intracellular exopeptidases. In: Proteinases in Mammalian Cells and Tissues, pp. 311-391, Barrett A. J. (ed.), North-Holland, Amsterdam
22. 22 Pshezhetsky A. V. (1998) Lysosomal carboxypeptidase A. In: Handbook of Proteolytic Enzymes. pp. 393-398, Barrett A. J., Rawlings N. D. and Woessner J. F. (eds). Academic Press, San Diego
23. 23 Kawamura Y., Matoba T., Hata T. and Doi E. (1974) Purification and some properties of cathepsin A of large molecular size from pig kidney. J. Biochem. 76: 915-924
24. 24 Galjart N. J., Morreau H., Willemsen R., Gillemans N., Bonten E. J. and d'Azzo A. (1991) Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J. Biol. Chem. 266: 14754-14762
25. 25 Itoh K., Takiyama N., Kase R., Kondoh K., Sano A., Oshima A. et al. (1993) Purification and characterization of human lysosomal protective protein expressed in stably transformed Chinese hamster ovary cells. J. Biol. Chem. 268: 1180-1186
26. 26 Jackman H. J., Tan F., Tamei H., Beurling-Harbury C., Li X.-Y., Skidgel R. A. et al. (1990) A deamidase in human platelets that deamidates tachykinins: probable identity with the lysosomal 'protective protein'. J. Biol. Chem. 265: 11265-11272
27. 27 Jackman H. J., Morris P. W., Deddish P. A., Skidgel R. A. and Erdös E. G. (1992) Inactivation of endothelin I by deamidase (lysosomal protective protein). J. Biol. Chem. 267: 2872-2875
28. 28 Itoh K., Kase R., Shimmoto M., Satake A., Sakuraba H. and Suzuki Y. (1995) Protective protein as an endogeneous endothelin degradation enzyme in human tissues, J. Biol. Chem. 270: 515-518
29. 29 d'Azzo A., Hoogeveen A. T., Reuser J. J., Robinson H. and Galjaard H. (1982) Molecular defect in combined β-galactosidase and neuraminidase deficiency in man. Proc. Natl. Acad. Sci. USA. 79: 4535-4539
30. 30 Vinogradova M. V., Michaud L., Mezentsev A. V., Lukong K. E., El-Alfy M., Morales C. R. et al. (1998) Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation. Biochem. J. 330: 641-650
31. 31 Zhou X. Y., Morreau H., Rottier R., Davis D., Bonten E., Gillemans N. et al. (1995) Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes Dev. 9: 2623-2634
32. 32 Galjart N. J., Gillemans N., Harris A., van der Horst G. T. J., Verheijen F. W., Galjaard H. et al. (1988) Expression of cDNA encoding the human 'protective protein' associated with lysosomal β-galactosidase and neuraminidase: homology to yeast proteases. Cell 54: 755-764
33. 33 Valls L. A., Hunter C. P., Rothman J. H. and Steven T. H. (1987) Protein sorting in yeast: the localization determinant of yeast vacuola carboxypeptidase Y residues in the propeptide. Cell 48: 887-897
34. 34 Bonten E. J., Galjart N. J., Willemsen R., Usmany M., Vlak J. M. and d'Azzo A. (1995) Lysosomal protective protein/ cathepsin A: role of the 'linker' domain in catalytic activation. J. Biol. Chem. 270: 26441-26445
35. 35 Rudenko G., Bonten E., d'Azzo A. and Hol W. G. J. (1995) Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism. Structure 3: 1249-1259
36. 36 Rudenko G., Bonten E., d'Azzo A. and Hol W. G. J. (1996) Structure determination of the human protective protein: twofold averaging reveals the three-dimensional structure of a domain which was entirely absent in the initial model. Acta Cryst. D52: 923-936
37. 37 Sørensen B. S., Svendsen I. and Breddam K. (1987) Primary structure of carboxypeptidase II from malted barley. Carlsberg Res. Commun. 52: 285-295
38. 38 Winther J. R. and Sørensen P. (1991) Propeptide of carboxypeptidase Y provides a chaperone-like function as well as inhibition of the enzyme activity. Proc. Natl. Acad. Sci. USA 88: 9330-9334
39. 39 Ollis D. L., Cheah E., Cygler M., Dijkstra B., Frolow F., Franken S. M. et al. (1992) The χ/β hydrolase fold. Protein Eng. 5: 197-211
40. 40 Endrizzi J. A., Breddam K. and Remington S. J. (1994) 2.8-Å structure of yeast serine carboxypeptidase. Biochemistry 33: 11106-11120
41. 41 Liao D. I., Breddam K., Sweet B., Bullock T. and Remington S. J. (1992) Refined atomic model of wheat serine carboxypeptidase II at 2.2 Å resolution. Biochemistry 31: 9796-9812
42. 42 George S. T. and Balasubramanian A. S. (1981) The aryl acylamidases and their relationship to cholinesterases in human serum, erythrocyte and liver. Eur. J. Biochem. 121: 177-186
43. 43 Boopathy R. and Balasubramanian A. S. (1987) A peptidase activity exhibited by human serum pseudocholinesterase. Eur. J. Biochem. 162: 191-197
44. 44 Chatonnet A. and Lockridge O. (1989) Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 260: 625-634
45. 45 Satake A., Itoh K., Shimmoto M., Saido T. C., Sakuraba H. and Suzuki Y. (1994) Distribution of lysosomal protective protein in human tissues. Biochem. Biophys. Res. Commun. 205: 38-43
46. 46 Galjart N. J., Gillemans N., Meijer D. and d'Azzo A. (1990) Mouse 'protective protein'. cDNA cloning, sequence comparison and expression. J. Biol. Chem. 265: 4678-4684
47. 47 Schechter I. and Berger A. (1967) On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27: 157-162
48. 48 Remington J. and Breddam K. (1994) Carboxypeptidases C and D. Methods Enzymol. 244: 231-248
49. 49 Hayashi R., Bai Y. and Hata T. (1975) Kinetic studies of carboxypeptidase Y. I. Kinetic parameters for the hydrolysis of synthetic substrates. J. Biochem. 77: 69-79
50. 50 Breddam K., Sørensen B. S. and Svenden I. (1987) Primary structure and enzymatic properties of carboxypeptidase II from wheat bran. Carlsberg Res. Commun. 52: 297-311
51. 51 Elsliger M.-A., Pshezhetsky A. V., Vinogradova M. V., Svedas V. K. and Potier M. (1996) Comparative modeling of substrate binding in the S1′ subsite of serine carboxypeptidases from yeast, wheat, and human. Biochemistry 35: 14899-14909
52. 52 Hiraiwa M., Saitoh M., Arai N., Shiraishi T., Odani S., Uda Y. et al. (1997) Protective protein in the bovine lysosomal β-galactosidase complex. Biochim. Biophys. Acta 1341: 189-199
53. 53 Fisher J. M. and Scheller R. H. (1988) Prohormone processing and the secretory pathway. J. Biol. Chem. 263: 16515-16518
54. 54 Sandberg E. B. and Iverson L. L. (1982) Substance P. J. Med. Chem. 25: 1009-1015
55. 55 Pernow B. (1983) Substance P. Pharmacol. Rev. 35: 85-141
56. 56 Fuller R. S., Sterne R. E. and Thorner J. (1988) Enzymes required for yeast prohormone processing. Ann. Rev. Physiol. 50: 345-362
57. 57 Rourke I. J., Johnsen A. H., Din N., Petersen J. G. L. and Reffeld J. F. (1997) Heterologous expression of human cholecystokinin in Saccharomyces cerevisiae. J. Biol. Chem. 272: 9720-9727
58. 58 Eipper B. A., Milgram S. L., Husten E. J., Yun H.-Y. and Mains R. E. (1993) Peptidylglycine χ-amidating monooxygenase: a multifunctional protein with catalytic, processing and routing domains. Protein Sci. 2: 489-497
59. 59 Newcomb R., Fisher J. M. and Scheller R. H. (1987) Processing of the egg-laying hormone (ELH) precursor in the bag cell neurons of Aplysia. J. Biol. Chem. 263: 12514-12521
60. 60 Matsuda K. (1976) Studies on cathepsins of rat liver lysosomes. III. Hydrolysis of peptides, and inactivation of angiotensin and bradykinin by cathepsin A. J. Biochem. 80: 659-669
61. 61 Miller J. J., Changaris D. G. and Levy R. S. (1988) Conversion of angiotensin I to angiotensin II by cathepsin A isozymes of poreine kidney. Biochem. Biophys. Res. Commun. 154: 1122-1129
62. 7 by a purified brain carboxypeptidase (cathepsin A). Peptides 2: 159-164
63. 7, presence in high amounts in brain of rat, cattle and man, is an opioid agonist. Nature 288: 88-90
64. 7) from bovine adrenal medullary granules and striatum. Proc. Natl. Acad. Sci. USA 76: 6680-6683
65. 65 Pshezhetsky A. V., Elsliger M. A., Vinogradova M. V. and Potier M. (1995) Human lysosomal β-galactosidase-cathepsin A complex: definition of the β-galactosidase-binding interface on cathepsin A. Biochemistry 34: 2431-2440
66. 66 Hatanaka M., Sasaki T., Kikuchi T. and Murachi T. (1985) Amidase-like activity of calpain I and calpain II on substance P and its related peptides. Arch. Biochem. Biophys. 242: 557-562
67. 67 Matsuzaki H., Ueno H., Hayashi R. and Liao T. H. (1998) Bovine spleen cathepsin A: characterization and comparison with the protective protein. J. Biochem. 123: 701-706
68. 68 Tranchemontagne J., Michaud L. and Potier M. (1990) Deficient lysosomal carboxypeptidase activity in galactosialidosis. Biochem. Biophys. Res. Commun. 168: 22-29
69. 69 Kase R., Itoh K., Takiyama N., Oshima A., Sakuraba H. and Suzuki Y. (1990) Galactosialidosis: simultaneous deficiency of esterase, carboxy-terminal deamidase and acid carboxypeptidase activities. Biochem. Biophys. Res. Commun. 172: 1175-1179
70. 70 Suzuki Y., Sakuraba H. and Oshima A. (1995) β-Galactosidase deficiency (β-Galactosidosis): GM1 gangliosidosis and Morquio B disease. In: The Metabolic and Molecular Basis of Inherited Disease, pp. 2785-2823, Scriver C. R., Beaudet A. L., Sly W. S. and Valle D. (eds), McGraw-Hill, New York
71. 71 Suzuki Y., Nakamura N., Fukuoka K., Shimada Y. and Uono M. (1977) Galaetosidase deficiency in juvenile and adult patients. Report of six Japanese cases and reviews of literature. Hum. Genet. 36: 219-229
72. 72 Wenger D. A., Tarby T. J. and Wharton C. (1978) Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and beta-galactosidase deficiencies. Biochem. Biophys. Res. Commun. 82: 589-595
73. 73 Andria G., Strisciuglo P., Pontarelli G., Sly W. S., and Dodson W. E. (1981) In: Sialidases and Sialidoses, pp. 365, Tettamanti G., Durand P. and DiDonato S. (eds), Ermes, Milan
74. 74 Suzuki Y., Sakuraba H., Hayashi K., Suzuki K. and Imahori K. (1981) β-Galactosidase-neuraminidase deficiency: restoration of β-galactosidase activity by protease inhibitors. J. Biochem. 90: 271-273
75. 75 van Diggelen O. P., Schram A. W., Sinnott M. L., Smith P. J., Robinson D. and Galjaard H. (1981) Turnover of β-galactosidase in fibroblasts from patients with genetically different types of β-galactosidase deficiency. Biochem. J. 200: 143-151
76. 76 Mueller O. T., Henry W., Haley L. L., Byers M. G., Eddy R. L. and Shows T. B. (1986) Sialidosis and galactosialidosis: chromosomal assignment of two genes associated with neuraminidase-deficiency disorders. Proc. Natl. Acad. Sci. USA 83: 1817-1821
77. 77 Hoeksema H. L., van Diggelen O. P. and Galjaard H. (1979) Intergenic complementation after fusion of fibroblasts from different patients with β-galactosidase deficiency. Biochim. Biophys. Acta 566: 72-79
78. 78 Hoogeveen A. T., Verheijen F. W. and Galjaard H. (1983) The relation between human lysosomal β-galactosidase and its protective protein. J. Biol. Chem. 258: 12143-12146
79. 79 Suzuki Y., Nanba E., Tsuji A., Yang R.-C, Okamura-Oho Y. and Yamanaka T. (1988) Clinical and genetic heterogeniety in galactosialidosis. Brain Dysfunct. 1: 285-293
80. 80 D'Agrosa R. M., Hubbes M., Zhang S., Shankaran R. and Callahan J. W. (1992) Characteristics of the β-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and β-galactosialidosis fibroblasts. Biochem. J. 285: 833-838
81. 81 Hiraiwa M, Tsuji S., Yamauchi T., Nishizawa M., Uda Y., and Miyatake T. (1988) Characterization of β-galactosidase in the liver of a patient with galactosialidosis. Proceedings of the 3rd Rinshoken International Conference on Biomedical Significance of Glycolipids, pp. 120-121
82. 82 Hoogeveen A., d'Azzo A., Brossmer R. and Galjaard H. (1981) Correction of combined β-galactosidase and neuraminidase deficiency in human fibroblasts. Biochem. Biophys. Res. Commun. 103: 292-300
83. 83 Verheijen F. W., Brossmer R. and Galjaard H. (1982) Purification of acid β-galactosidase and acid neuraminidase from bovine testis: evidence for an enzyme complex. Biochem. Biophys. Res. Commun. 108: 868-875
84. 84 Verheijen F. W., Palmeri S., Hoogeveen A. T. and Galjaard H. (1985) Human placental neuraminidase: activation, stabilization and association with β-galactosidase and its protective protein. Eur. J. Biochem. 149: 315-321
85. 85 Potier M., Michaud L., Tranchemontagne J. and Thauvette L. (1990) Structure of the lysosomal neuraminidase-β-galactosidase-carboxypeptidase multimeric complex. Biochem. J. 267: 197-202
86. 86 Hubbes M., D'Agrosa R. M. and Callahan J. W. (1992) Human placental β-galactosidase. Characterization of the dimer and complex forms of the enzyme. Biochem. J. 285: 827-831
87. 87 Pshezhetsky A. V. and Potier M. (1994) Direct affinity purification and supramolecular organization of human lysosomal cathepsin A. Arch. Biochem. Biophys. 313: 64-70
88. 88 Hiraiwa M., Saitoh M., Uda Y., Azuma N., Martin B. M., Kishimoto Y. et al. (1996) A sialidase complex from chicken liver: characterization of a multienzyme complex with β-galactosidase and carboxypeptidase. Comp. Biochem. Physiol. 115B: 541-546
89. 89 Pshezhetsky A. V. and Potier M. (1993) Stoichiometry of the human lysosomal carboxypeptidase-β-galactosidase complex. Biochem. Biophys. Res. Commun. 195: 354-363
90. 90 Bonten E., van der Spoel A., Fornerod M., Grosveld G. and d'Azzo A. (1996) Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev. 10: 3156-3169
91. 91 Pshezhetsky A. V., Richard C., Michaud L., Igdoura S., Wang S., Elsliger M.-A. et al. (1997) Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nature Genet. 15: 316-320
92. 92 Kishimoto Y., Hiraiwa M. and O'Brien J. S. (1992) Saposins: structure, function, distribution and molecular genetics. J. Lipid Res. 33: 1255-1267
93. 93 D'Agrosa R. M. and Callahan J. W. (1988) In vitro activation of neuraminidase in the β-galactosidase-neuraminidase-protective protein complex by cathepsin C. Biochem. Biophys. Res. Commun. 157: 770-775
94. 94 van der Horst G. T. J., Galjart N. J., d'Azzo A., Galjaard H. and Verheijen F. W. (1989) Identification and in vitro reconstitution of lysosomal neuraminidase from human placenta. J. Biol. Chem. 264: 1317-1322
95. 95 Hiraiwa M., Uda Y., Nishizawa M. and Miyatake T. (1987) Human placental sialidase: partial purification and characterization. J. Biochem. 101: 1273-1279
96. 96 Hiraiwa M., Yamauchi T., Tsuji S., Nishizawa M., Miyatake T., Oyanagi K. et al. (1993) Activation of human lysosomal sialidase. J. Biochem. 114: 901-905
97. 97 van der Spoel A., Bonten E. and d'Azzo A. (1998) Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A. EMBO J. 17: 1588-1597
98. 98 Okamura-Oho Y., Zhang S. and Callahan J. W. (1994) The biochemistry and clinical features of galactosialidosis. Biochim. Biophys. Acta 1225: 244-254
99. 99 d'Azzo A., Andria G., Strisciuglio P. and Galjaard H. (1995) Galactosialidosis. In: The Metabolic and Molecular Basis of Inherited Disease, pp. 2825-2837, Scriver C. R., Beaudet A. L., Sly W. S. and Valle D. (eds), McGraw-Hill, New York
100. 100 Suzuki Y. (1997) Lysosomal enzymes, sphingolipid activator proteins and protective protein. Nippon Rinsho 53: 2887-2891
101. 101 Hirasawa M. (1995) Galactosialidosis: protective protein and related enzymes. Nippon Rinsho 53: 2967-2972
102. 102 Lowden J. A. and O'Brien J. S. (1979) Sialidosis: a review of human neuraminidase deficiency. Am. J. Hum. Genet. 31: 1-18
103. 103 Zammarchi E., Donati M. A., Morrone A., Donzelli G. P., Zhou X. Y. and d'Azzo A. (1996) Early-infantile galactosialidosis: clinical, biochemical and molecular observations in a new patient. Am. J. Med. Genet. 64: 453-458
104. 104 Shimmoto M., Fukuhara Y., Itoh K., Oshima A., Sakuraba H. and Suzuki Y. (1993) Protective protein gene mutations in galactosialidosis. J. Clin. Invest. 91: 2393-2398
105. 105 Zhou X. Y., van der Spoel A., Rottier R., Hale G., Willemsen R., Berry G. T. et al. (1996) Molecular and biochemcal analysis of protective protein/cathepsin A mutations: correlation with clinical severity in galactosialidosis. Hum. Mol. Genet. 5: 1977-1987
106. 106 Fukuhara Y., Takano T., Shimmoto M., Oshima A., Takeda E., Kuroda Y. et al. (1992) A new point mutation of protective protein gene in two Japanese siblings with juvenile galactosialidosis. Brain Dysfunct. 5: 319-325
107. 107 Takano T., Shimmoto M., Fukuhara Y., Itoh K., Kase R., Takiyama N. et al. (1991) Galactosialidosis: clinical and molecular analysis of 19 Japanese patients. Brain Dysfunct. 4: 271-280
108. 108 Richard C., Tranchemontagne J., Elsliger M. A., Mitchell G. A., Potier M. and Pshezhetsky A. V. (1998) Molecular pathology of galactosialidosis in a patient affected with two new frameshift mutations in the cathepsin A/protective protein gene. Hum. Mutation 11: 461-469
109. 109 Itoh K., Shimmoto M., Utsumi K., Mizoguchi N., Miharu N., Ohama K. et al. (1998) Protective protein 'cathepsin A loss in cultured cells derived from an early-infantile form of galactosialidosis patients homozygous for the A1184-G transition (Y395C mutation). Biochem. Biophys. Res. Commun. 247: 12-17
110. 110 Shimmoto M., Takano T., Fukuhara Y., Oshima A., Sakuraba H. and Suzuki Y. (1990) A unique and common splice junction mutation causing exon skipping in the protective protein/carboxypeptidase gene. Proc. Jpn. Acad. 66B: 217-222
111. 111 Oyanagi K., Ohama E., Miyashita K., Yoshino H., Miyatake T., Yamasaki M. et al. (1991) Galactosialidosis: neuropathological findings in a case of the late-infantile type. Acta Neuropathol. 82: 331-339
112. 112 Tsuji S., Hiraiwa M., Yamauchi T., Nishizawa M., Uda Y., and Miyatake T. (1988) Biomedical studies of sialidase in sialidoses. Proceedings of the 3rd Rinshoken International Conference on Biomedical Significance of Glycolipids. pp. 40-41
113. 113 Yoshino H., Miyashita K., Miyatani N., Ariga T., Hashimoto Y., Tsuji S. el al. (1990) Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis. J. Neurol. Sci. 97: 53-65
114. 114 Zhou X. Y., Galjart N. J., Willemsen R., Gillemans N., Galjaard H. and d'Azzo A. (1991) A mutation in a mild form of galactosialidosis impairs dimerization of protective protein and renders it unstable. EMBO J. 10: 4041-4048
115. 115 Rudenko G., Bonten E., Hol W. G. J. and d'Azzo A. (1998) The atomic model of the human protective protein cathepsin A. Proc. Natl. Acad. Sci. USA 95: 621-625
116. 116 Hahn C. N., del Pilar Martin M., Zhou X. Y., Mann L. W. and d'Azzo A. (1998) Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter. Proc. Natl. Acad. Sci. USA 95: 14880-14885